Susquehanna International Group, LLP Pro Phase Labs, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$4.23 - $7.53 $110,826 - $197,286	-26,200 Reduced 41.72%	36,600 $159,000
Q2 2023 Aug 11, 2023	BUY	$7.15 - $9.78 $298,870 - $408,804	41,800 Added 199.05%	62,800 $455,000
Q1 2023 May 16, 2023	BUY	$6.62 - $9.57 $7,282 - $10,527	1,100 Added 5.53%	21,000 $160,000
Q4 2022 Feb 14, 2023	SELL	$8.78 - $12.47 $16,682 - $23,693	-1,900 Reduced 8.72%	19,900 $191,000
Q3 2022 Nov 14, 2022	BUY	$8.96 - $14.7 $85,120 - $139,650	9,500 Added 77.24%	21,800 $246,000

1.67M

500

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $36.4M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.